(OTLK) Outlook Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Outlook Therapeutics | (OTLK) share price targets
Complete technical analysis of Outlook Therapeutics (OTLK) by charts plus indicators, forecast predictions and share price targets for Outlook Therapeutics (OTLK)
Outlook Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2025-03-10 View latest technical analysis
10 day averaged volume of Outlook Therapeutics is 499065
| Date | Daily Closing Price | Open | High | Low | Volume |
| 10 Mon Mar 2025 | 1.41 | 1.48 | 1.50 | 1.40 | 0.477 times |
| 07 Fri Mar 2025 | 1.49 | 1.51 | 1.52 | 1.46 | 0.452 times |
| 06 Thu Mar 2025 | 1.51 | 1.48 | 1.53 | 1.47 | 0.524 times |
| 05 Wed Mar 2025 | 1.50 | 1.50 | 1.56 | 1.47 | 0.868 times |
| 04 Tue Mar 2025 | 1.47 | 1.42 | 1.52 | 1.36 | 0.541 times |
| 03 Mon Mar 2025 | 1.42 | 1.56 | 1.57 | 1.41 | 1.407 times |
| 28 Fri Feb 2025 | 1.50 | 1.39 | 1.59 | 1.32 | 2.639 times |
| 27 Thu Feb 2025 | 1.38 | 1.49 | 1.50 | 1.36 | 0.941 times |
| 26 Wed Feb 2025 | 1.50 | 1.49 | 1.54 | 1.44 | 0.795 times |
| 25 Tue Feb 2025 | 1.48 | 1.54 | 1.54 | 1.44 | 0.826 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 1.4 as stoploss in an intra day buy trade for a target of 1.58. However, stock will show a bearish move below 1.4.
Share price targets for Outlook Therapeutics (OTLK)
| Target Type | Value |
| Downside Target | 1.26 |
| Downside Target | 1.32 |
| Downside Target | 1.36 |
| Downside Target | 1.40 |
| Upside Target | 1.50 |
| Upside Target | 1.53 |
| Upside Target | 1.57 |
| Upside Target | 1.80 |
| Upside Target | 1.88 |
| Upside Target | 1.99 |
| Upside Target | 2.18 |
| Upside Target | 2.60 |
| Upside Target | 4.84 |
| Upside Target | 6.98 |
Intraday share price targets for Outlook Therapeutics (OTLK)
| Target Type | Value |
| Downside Intraday Target | 1.37 |
| Downside Intraday Target | 1.34 |
| Upside Intraday Target | 1.47 |
| Upside Intraday Target | 1.54 |
| Upside Intraday Target | 1.44 |
Weekly technical analysis of Outlook Therapeutics (OTLK)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 10 Mon Mar 2025 | 1.41 | 1.48 | 1.50 | 1.40 | 0.126 times |
| 07 Fri Mar 2025 | 1.49 | 1.56 | 1.57 | 1.36 | 0.611 times |
| 28 Fri Feb 2025 | 1.50 | 1.56 | 1.59 | 1.32 | 1.365 times |
| 21 Fri Feb 2025 | 1.56 | 1.85 | 1.88 | 1.53 | 0.806 times |
| 14 Fri Feb 2025 | 1.87 | 1.73 | 1.99 | 1.59 | 0.722 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Outlook Therapeutics (OTLK)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 10 Mon Mar 2025 | 1.41 | 1.56 | 1.57 | 1.36 | 0.176 times |
| 28 Fri Feb 2025 | 1.50 | 1.97 | 1.99 | 1.32 | 0.565 times |
| 31 Fri Jan 2025 | 2.06 | 1.90 | 2.60 | 1.80 | 1.161 times |
| 31 Tue Dec 2024 | 1.89 | 1.53 | 2.18 | 1.26 | 3.293 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Outlook Therapeutics (OTLK)
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Outlook Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Outlook Therapeutics in short term but the buy signal is initial and weak.
Outlook Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Outlook Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Outlook Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.47 and Outlook Therapeutics (OTLK) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Outlook Therapeutics (OTLK) stock. Volume based technical analysis of Outlook Therapeutics (OTLK) stock is negative.
Outlook Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Outlook Therapeutics ( (OTLK) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Outlook Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Outlook Therapeutics in short term but the buy signal is initial and weak.
Outlook Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Outlook Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Outlook Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.47 and Outlook Therapeutics (OTLK) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Outlook Therapeutics (OTLK) stock. Volume based technical analysis of Outlook Therapeutics (OTLK) stock is negative.
Outlook Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.